ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,604,217 | +13.9% | 230,491 | -12.7% | 0.08% | -9.5% |
Q3 2022 | $1,409,000 | +123.3% | 263,924 | +67.0% | 0.08% | +180.0% |
Q2 2022 | $631,000 | -10.1% | 158,031 | 0.0% | 0.03% | +7.1% |
Q1 2022 | $702,000 | +8.2% | 158,031 | -2.5% | 0.03% | +21.7% |
Q4 2021 | $649,000 | +15.9% | 162,134 | +154.2% | 0.02% | +27.8% |
Q3 2021 | $560,000 | – | 63,786 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |